Market Opportunity Target mental health agencies and clinics seeking telemedicine expansion to at-home ketamine therapies, leveraging KetaMD’s HIPAA-compliant platform to extend reach in Florida and beyond where the service has recently launched.

Expansion Potential Capitalize on past Florida launches and upcoming nationwide opportunities by positioning as a turnkey telemedicine ketamine solution for states exploring at-home treatment models, offering scalable onboarding and compliance.

Technology Advantage Promote the secure, nurse-guided platform with modern tech stack as a differentiator for healthcare partners prioritizing patient safety, data privacy, and seamless provider workflows.

Strategic Partnerships Leverage recent acquisition and leadership changes to propose collaborations with telemedicine networks, compliant EHR integrations, and ancillary mental health service providers to accelerate market penetration.

Revenue & Deals Focus on mid-market clinics and regional health systems with 1M–10M revenue bands similar to peers, highlighting low upfront costs, scalable patient access, and potential for co-branded offerings to drive revenue growth.